Streetbeat News

Stock Prices

GILD

Gilead Sciences (NASDAQ:GILD) has outperformed the market over the past 20 years with an average annual return of 11.47%. A $100 investment in GILD 20 years ago would be worth $889.70 today. The article highlights the impact of compounded returns over time.

Portfolio Pulse from Benzinga Insights

August 22, 2024 | 4:01 pm

IART

Integra Lifesciences (NASDAQ:IART) has been analyzed by 8 analysts, showing a range of opinions from bullish to bearish. Recent ratings indicate a shift towards bearish sentiment, with a decline in the average 12-month price target. Analysts have adjusted their ratings and price targets in response to market conditions and company performance. Despite a strong revenue growth rate, Integra's market capitalization is below industry benchmarks.

Portfolio Pulse from Benzinga Insights

August 22, 2024 | 4:00 pm

BSX

In the past three months, 18 analysts have shared their insights on Boston Scientific (NYSE:BSX), with most ratings being bullish. The average 12-month price target has increased by 6.27% to $87.33. Analysts have raised their ratings and price targets, reflecting positive sentiment towards the company. Boston Scientific has shown revenue growth and strong net margins, but faces challenges with ROE and ROA.

Portfolio Pulse from Benzinga Insights

August 22, 2024 | 4:00 pm

ALC

Alcon Inc. (NYSE:ALC) reported mixed Q2 results, with earnings beating estimates but sales missing. Analysts raised their price targets for Alcon, reflecting optimism about future growth. The company anticipates FY24 earnings of $3.00-$3.10 per share on $9.9-$10.1 billion revenue.

Portfolio Pulse from Avi Kapoor

August 22, 2024 | 4:00 pm

HAE

Haemonetics (NYSE:HAE) has received mixed analyst ratings over the past three months, with a current average price target of $107.5. Analysts have adjusted their ratings and price targets in response to market conditions, with some maintaining or raising their outlook. Haemonetics has shown solid financial performance, with notable revenue growth and strong profitability metrics.

Portfolio Pulse from Benzinga Insights

August 22, 2024 | 4:00 pm

DVN

Devon Energy Inc. (NYSE:DVN) is trading at $43.98, with a recent increase of 0.31%. Despite this, the stock has decreased by 4.97% over the past month and 12.79% over the past year. Its P/E ratio of 7.93 is lower than the industry average of 17.64, suggesting potential undervaluation or low future growth expectations.

Portfolio Pulse from Benzinga Insights

August 22, 2024 | 4:00 pm

OKE

ONEOK (NYSE:OKE) has been analyzed by 7 analysts, showing a range of opinions from bullish to indifferent. Recent analyst actions include raised price targets, with an average target of $88.86, up from $85.43. ONEOK's financials show strong revenue growth but challenges in profitability and returns.

Portfolio Pulse from Benzinga Insights

August 22, 2024 | 4:00 pm

FFIE

Faraday Future Intelligent Electric shares experienced a trading halt due to a circuit breaker triggered by a sharp decline. Despite this, the stock surged by 102.8%.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 4:00 pm

GDC

GD Culture shares were halted due to a circuit breaker as the stock surged by 62.5%.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 3:57 pm

URBN

Urban Outfitters reported better-than-expected Q2 results with earnings of $1.24 per share and record sales of $1.35 billion. Despite this, the stock fell 8.9% as analysts adjusted their price targets, reflecting mixed sentiment.

Portfolio Pulse from Avi Kapoor

August 22, 2024 | 3:52 pm